2026-01-26 - Analysis Report
**Lam Research (LRCX) Analysis Report**
=====================================

### Company Overview
Lam Research is a leading provider of semiconductor manufacturing equipment and services.

### Return Rate Comparison
| **Ticker** | **Cumulative Return** | **Rate Vs** | **Divergence** | **Relative Divergence** |
| --- | --- | --- | --- | --- |
| LRCX | 863.53% | VOO | 736.12% | 94.00% |

The company's cumulative return has significantly surpassed the S&P 500 average, indicating a substantial divergence in growth performance.

### Alpha, Beta Analysis
| **Year** | **CAGR** | **MDD** | **Alpha** | **Beta** | **Cap (B)** |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | 14.0% | 33.7% | 2.0% | 1.6 | 17.2B |
| 2017-2019 | 89.0% | 33.7% | 64.0% | 1.7 | 36.9B |
| 2018-2020 | 147.0% | 44.4% | 122.0% | 1.5 | 59.5B |
| 2019-2021 | 293.0% | 44.4% | 228.0% | 1.6 | 90.7B |
| 2020-2022 | 2.0% | 54.3% | -5.0% | 1.6 | 53.0B |
| 2021-2023 | 65.0% | 54.3% | 44.0% | 1.8 | 98.8B |
| 2022-2024 | -11.0% | 45.7% | -41.0% | 1.9 | 91.1B |
| 2023-2025 | 482.0% | 46.1% | 407.0% | 2.0 | 215.9B |

The company's Alpha and Beta values indicate that it has outperformed the market while maintaining relatively high volatilty.

### Recent Stock Price Fluctuations
| **Metric** | **Value** |
| --- | --- |
| Close | $217.94 |
| 5-day SMA | $222.48 |
| 20-day SMA | $202.94 |
| 60-day SMA | $173.42 |

The recent stock price fluctuations indicate a downward trend, with the 5-day SMA above the close price and the 20-day SMA below.

### RSI, PPO Index Indicators
| **Metric** | **Value** |
| --- | --- |
| RSI | 68.25 |
| PPO | -0.06 |
| MRI | 0.70 (Medium Investment) |

The RSI and PPO values indicate a slightly overbought market, while the MRI suggests a medium-risk investment.

### Recent News & Significant Events
| **Date** | **News Headline** |
| --- | --- |
| 2026-01-09 | Why Is Lam Research (LRCX) Stock Soaring Today |
| 2026-01-23 | LRCX Likely to Beat Q2 Earnings Estimates: Should You Buy the Stock? |
| 2026-01-23 | Lam Research (NASDAQ:LRCX) Stock Price Down 1.3% |
| 2026-01-21 | $LRCX stock is up 2% today. Here's what we see in our data. |
| 2026-01-23 | Lam Research Stock vs Competition: Who Wins? |
| 2026-01-02 | The Memory Market Is Going to Boom in 2026: 1 Top Stock to Buy Hand Over Fist Before It Skyrockets |

### Analyst Opinions
**Analyst Consensus:**

- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.72 (~Buy)
- Opinions: 31
- Target Price (avg/high/low): 213.06 / 265.00 / 115.00

The analyst consensus suggests a strong buying sentiment, with a target price range of $213.06 to $265.00.

### Recent Earnings Analysis
| **Date** | **EPS** | **Revenue** |
| --- | --- | --- |
| 2025-10-24 | 1.24 | $5.32B |
| 2025-04-25 | 1.04 | $4.72B |
| 2025-01-31 | 0.93 | $4.38B |
| 2024-10-28 | 0.86 | $4.17B |
| 2025-10-24 | 0.86 | $4.17B |

The company's recent earnings have shown a decline in EPS and revenue, with a slight recovery in the last quarter.

### Financial Information
**Revenue and Profitability:**

| **Quarter** | **Revenue** | **Profit Margin** |
| --- | --- | --- |
| 2025-09-30 | $5.32B | 50.43% |
| 2025-06-30 | $5.17B | 50.08% |
| 2025-03-31 | $4.72B | 49.02% |
| 2024-12-31 | $4.38B | 47.37% |
| 2024-09-30 | $4.17B | 48.05% |

**Capital and Profitability:**

| **Quarter** | **Equity** | **ROE** |
| --- | --- | --- |
| 2025-09-30 | $10.19B | 15.39% |
| 2025-06-30 | $9.86B | 17.44% |
| 2025-03-31 | $9.51B | 13.99% |
| 2024-12-31 | $8.81B | 13.52% |
| 2024-09-30 | $8.47B | 13.18% |

The company's revenue and profitability have declined in recent quarters, while the Return on Equity (ROE) has remained relatively stable.

### Comprehensive Analysis (Summary)
The analysis suggests a strong divergence in growth performance between Lam Research and the S&P 500, with a medium-risk investment recommendation based on the RSI and PPO values. The recent news and significant events indicate a positive sentiment towards the company, while the analyst consensus suggests a strong buying sentiment. However, the recent earnings and financial information indicate a decline in revenue and profitability, which may be a concern for investors.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.